Search filters

List of works by Mark Agulnik

A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas

scientific article

A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium

scientific article published on 3 August 2010

A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma ⬇️

scientific article published on April 27, 2012

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.

scientific article published on 5 March 2013

Assessment of multimodality therapy use for extremity sarcoma in the United States

scientific article

Bone cancer

scientific article

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial

scientific article

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

scientific article

Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: a pilot study

scientific article

Effect of recombinant human deoxyribonuclease on oropharyngeal secretions in patients with head-and-neck cancers treated with radiochemotherapy

scientific article

Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received ca

scientific article published in September 2008

Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma

scientific article published on 7 June 2014

Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib

scientific article published on August 2009

Head and neck cancer: changing epidemiology and public health implications

scientific article published on September 1, 2010

Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents

scientific article published on October 2006

Malignancies of the head and neck: the role for molecular targeted agents

scientific article published on February 2007

Management of Neuroendocrine Tumors of Unknown Origin ⬇️

scientific article published on December 1, 2011

NCCN Clinical Practice Guidelines Occult primary

scientific article

NCCN Guidelines Insights: Bone Cancer, Version 2.2017.

scientific article

Nasopharyngeal carcinoma: current management, future directions and dental implications

scientific article published on 03 December 2007

New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN) ⬇️

scientific article published on January 18, 2012

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma ⬇️

scientific article published on August 11, 2011

New therapeutic options in gastrointestinal stromal tumors

scientific article published on February 2008

Occult primary

scientific article

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

scientific article

Olaratumab for advanced soft tissue sarcoma

scientific article published on 27 April 2017

Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer

scientific article

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.

scientific article published on 12 September 2016

Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck ⬇️

scientific article published on April 17, 2012

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

scientific article

Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib

scientific article published on June 2007

Promising new molecular targeted therapies in head and neck cancer

scientific article published on March 2013

Promising newer molecular-targeted therapies in head and neck cancer

scientific article published in January 2008

Recent advances in the treatment of oligodendrogliomas

scientific article

Salivary gland malignancies: the role for chemotherapy and molecular targeted agents

scientific article published on June 2008

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives

scientific article

Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies

scientific article published on 5 April 2017

Targeted therapies in advanced differentiated thyroid cancer

scientific article published on 17 June 2015

Targeted therapies in bone sarcomas: current approach and future directions ⬇️

scientific article published on April 22, 2011

Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas

scientific article published on 10 August 2015

Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib

scientific article published on 13 February 2014

The role of inhibitors of the epidermal growth factor in management of head and neck cancer.

scientific article published on August 2008

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials

scientific article

Treatment of multiple keratoacanthomas with erlotinib

scientific article published on 11 March 2010

Understanding rechallenge and resistance in the tyrosine kinase inhibitor era: imatinib in gastrointestinal stromal tumor

scientific article published on August 2014

Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma

scientific article

Paulina is supported by:

About Paulina

Help